Posted May 28, 2015

The IFOPA is pleased to share news that Clementia Pharmaceuticals Natural History Study of patients with Fibrodysplasia Ossificans Progressiva (FOP) has commenced enrollment in the second part (Part B).

Part B will enroll 40 patients from two to 65 years of age. To download and read the entire announcement please click on Clementia NHS Study Update Release May 2015.

To help you learn more, click on our Clementia FOP Natural History Study website page for an informational video, Frequently Asked Questions and access a direct government link.

Please click on IFOPA's Clinical Trial Latest News to read information about the ongoing palovarotene clinical trial.